The consequences of extended newborn screening programmes: Do we know who needs treatment?

Abstract

The development of an evidence base for newborn screening is especially difficult because of the rarity of disorders now detectable. One consequence of expanded newborn screening is that physicians are being called upon to manage asymptomatic babies with persistent biochemical disturbances that indicate likely enzyme deficiencies. Some of these may be very mild. There is not always agreement as to who should be treated. Particular problems are seen with disorders that were previously thought very rare but are now found frequently by newborn screening. Some of these disorders appear benign or nearly so, and in the present state of knowledge should clearly not be included in routine newborn screening panels.

DOI: 10.1007/s10545-008-0843-8

1 Figure or Table

02004006002008200920102011201220132014201520162017
Citations per Year

818 Citations

Semantic Scholar estimates that this publication has 818 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Wilcken2008TheCO, title={The consequences of extended newborn screening programmes: Do we know who needs treatment?}, author={Bridget M Wilcken}, journal={Journal of Inherited Metabolic Disease}, year={2008}, volume={31}, pages={173-177} }